Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 24, 2025
Accession Number:
0001193125-25-042780
Submission Type:
POS AM
CIK:
0001650648
Company Name:
4D Molecular Therapeutics, Inc.
File Number:
333-276872